IQV earnings call for the period ending June 30, 2020.
News & Analysis: IQVIA Holdings, Inc.
Here’s why Veeva Systems is the better choice for investors looking for exposure to companies performing clinical trial analytics.
IQV earnings call for the period ending March 31, 2020.
Disruptions in clinical trials and delayed regulatory decisions could slow the rate of new drug approvals.
Headwinds from COVID-19 may negatively impact 2020 projections.
IQV earnings call for the period ending December 31, 2019.
Many investors aren’t aware of the vital roles contract research organizations fulfill for pharmaceutical and biotech companies -- or of the billions they make each year for their services.
IQV earnings call for the period ending September 30, 2019.
In the high-risk world of biotech investing, there are no guarantees of success. Still, sometimes investors can find places where the odds look reasonable enough to consider buying shares.
Everything is going well for the life sciences service provider.